Found 0 matching trials
High-selenium Lentils Versus Arsenic Toxicity
NAAbout 45 million people in Bangladesh are chronically exposed to unacceptab...
Location
Field Office, International Centre for Diarrhoeal Disease Research, Bangladesh
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
PHASE3CanTreatCOVID is an open-label, individually randomized, multi-centre, nati...
Status
Active Not Recruiting
Location
The Governors of the University of Calgary
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer
PHASE2RATIONALE: Selenomethionine may slow the growth of prostate cancer. Giving ...
Location
Multiple Locations
Males, Antioxidants, and Infertility Trial
PHASE2The objective of the Males, Antioxidants, and Infertility (MOXI) Trial is t...
Location
Keck School of Medicine of University of Southern California
A New Nutritional Countermeasure to Prevent the Deconditioning Induced by 60 Days of Antiorthostatic Bed Rest
NAThe objective of this study is to investigate whether the cocktail of natur...
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
PHASE1RATIONALE: The use of nutritional supplements, such as selenium, may stop p...
Location
Roswell Park Cancer Institute
Role of Antioxidants Supplementation in Chronic Pancreatitis
PHASE3Chronic pancreatitis is a progressive inflammatory disease of the pancreas ...
Study on Serum Zinc and Selenium Levels in Epileptic Patients
N/AThis study was carried out with the purpose of evaluating zinc and selenium...
Location
Vali-Asr Hospital
Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso
PHASE4Intrauterine Growth Retardation is the most important determinant of mortal...
Location
Centre Muraz, 2054, Avenue Mamadou KONATE
Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
PHASE1RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in differen...
Location
Roswell Park Cancer Institute